Boundless Bio, Inc. (BOLD)
2.45
-0.05
(-2.00%)
USD |
NASDAQ |
Jul 08, 12:14
Boundless Bio Market Cap : 54.90M for July 8, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| July 07, 2026 | 56.02M |
| July 06, 2026 | 56.02M |
| July 02, 2026 | 56.02M |
| July 01, 2026 | 55.57M |
| June 30, 2026 | 56.02M |
| June 29, 2026 | 54.90M |
| June 26, 2026 | 57.36M |
| June 25, 2026 | 56.24M |
| June 24, 2026 | 58.26M |
| June 23, 2026 | 58.26M |
| June 22, 2026 | 31.37M |
| June 18, 2026 | 32.04M |
| June 17, 2026 | 31.37M |
| June 16, 2026 | 31.59M |
| June 15, 2026 | 31.37M |
| June 12, 2026 | 31.59M |
| June 11, 2026 | 31.15M |
| June 10, 2026 | 30.92M |
| June 09, 2026 | 31.37M |
| June 08, 2026 | 32.04M |
| June 05, 2026 | 31.82M |
| June 04, 2026 | 32.94M |
| June 03, 2026 | 32.27M |
| June 02, 2026 | 32.04M |
| June 01, 2026 | 32.27M |
| Date | Value |
|---|---|
| May 29, 2026 | 32.49M |
| May 28, 2026 | 32.71M |
| May 27, 2026 | 33.02M |
| May 26, 2026 | 33.02M |
| May 22, 2026 | 32.35M |
| May 21, 2026 | 32.57M |
| May 20, 2026 | 31.90M |
| May 19, 2026 | 31.45M |
| May 18, 2026 | 31.90M |
| May 15, 2026 | 33.47M |
| May 14, 2026 | 34.82M |
| May 13, 2026 | 34.59M |
| May 12, 2026 | 33.70M |
| May 11, 2026 | 34.82M |
| May 08, 2026 | 32.35M |
| May 07, 2026 | 34.37M |
| May 06, 2026 | 35.49M |
| May 05, 2026 | 35.27M |
| May 04, 2026 | 35.18M |
| May 01, 2026 | 35.18M |
| April 30, 2026 | 32.71M |
| April 29, 2026 | 32.49M |
| April 28, 2026 | 32.27M |
| April 27, 2026 | 32.94M |
| April 24, 2026 | 33.61M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| AbbVie, Inc. | 448.93B |
| ACADIA Pharmaceuticals, Inc. | 4.390B |
| Alnylam Pharmaceuticals, Inc. | 42.65B |
| Anika Therapeutics, Inc. | 211.91M |
| Savara, Inc. | 1.271B |
Market Cap Related Metrics
| Price to Book Value | 0.6355 |
| Price | 2.45 |
| Earnings Yield | -102.1% |